Yuji Motoi
Chiba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
TLR7 responses to nucleosides drive sialadenitis in Slc29a3-deficient mice.
Journal: International immunology
Published: September 24, 2025
TLR7 responses to nucleosides drive sialadenitis in Slc29a3-deficient mice.
Journal: International immunology
Published: September 24, 2025
Anti-human TLR7 antibody for therapeutic intervention in systemic lupus erythematosus.
Journal: International immunology
Published: April 17, 2025
RNase T2 deficiency promotes TLR13-dependent replenishment of tissue-protective Kupffer cells.
Journal: The Journal of experimental medicine
Published: April 17, 2023
TLR7/8 stress response drives histiocytosis in SLC29A3 disorders.
Journal: The Journal of experimental medicine
Published: January 10, 2023
Anti-TLR7 Antibody Protects Against Lupus Nephritis in NZBWF1 Mice by Targeting B Cells and Patrolling Monocytes.
Journal: Frontiers in immunology
Published: September 15, 2021
The impact of cell maturation and tissue microenvironments on the expression of endosomal Toll-like receptors in monocytes and macrophages.
Journal: International immunology
Published: January 24, 2020
Cytidine deaminase enables Toll-like receptor 8 activation by cytidine or its analogs.
Journal: International immunology
Published: October 06, 2018
Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
Journal: The Journal of biological chemistry
Published: April 18, 2017
Identification of biomarker sets for predicting the efficacy of sublingual immunotherapy against pollen-induced allergic rhinitis.
Journal: International immunology
Published: January 16, 2017
Arl8b is required for lysosomal degradation of maternal proteins in the visceral yolk sac endoderm of mouse embryos.
Journal: Journal of cell science
Published: December 11, 2016
The protective effect of the anti-Toll-like receptor 9 antibody against acute cytokine storm caused by immunostimulatory DNA.
Journal: Scientific reports
Published: September 26, 2016
Last Updated: 09/26/2026